These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virus. Ferenczy MW Curr Pharm Des; 2007; 13(19):1975-88. PubMed ID: 17627531 [TBL] [Abstract][Full Text] [Related]
5. Vaccines for Herpes Simplex: Recent Progress Driven by Viral and Adjuvant Immunology. Sandgren KJ; Truong NR; Smith JB; Bertram K; Cunningham AL Methods Mol Biol; 2020; 2060():31-56. PubMed ID: 31617171 [TBL] [Abstract][Full Text] [Related]
6. Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses. Stanfield BA; Kousoulas KG; Fernandez A; Gershburg E Viruses; 2021 Aug; 13(8):. PubMed ID: 34452501 [TBL] [Abstract][Full Text] [Related]
7. Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017. Gottlieb SL; Giersing BK; Hickling J; Jones R; Deal C; Kaslow DC; Vaccine; 2019 Nov; 37(50):7408-7418. PubMed ID: 29224963 [TBL] [Abstract][Full Text] [Related]
8. Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model. Manservigi R; Boero A; Argnani R; Caselli E; Zucchini S; Miriagou V; Mavromara P; Cilli M; Grossi MP; Balboni PG; Cassai E Vaccine; 2005 Jan; 23(7):865-72. PubMed ID: 15603886 [TBL] [Abstract][Full Text] [Related]
9. Status of vaccine research and development of vaccines for herpes simplex virus. Johnston C; Gottlieb SL; Wald A Vaccine; 2016 Jun; 34(26):2948-2952. PubMed ID: 26973067 [TBL] [Abstract][Full Text] [Related]
10. Developments in herpes simplex virus vaccines: old problems and new challenges. Rajcáni J; Durmanová V Folia Microbiol (Praha); 2006; 51(2):67-85. PubMed ID: 16821715 [TBL] [Abstract][Full Text] [Related]
12. Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines. Stanberry LR Herpes; 2004 Aug; 11 Suppl 3():161A-169A. PubMed ID: 15319086 [TBL] [Abstract][Full Text] [Related]
13. Modelling efforts needed to advance herpes simplex virus (HSV) vaccine development: Key findings from the World Health Organization Consultation on HSV Vaccine Impact Modelling. Gottlieb SL; Giersing B; Boily MC; Chesson H; Looker KJ; Schiffer J; Spicknall I; Hutubessy R; Broutet N; Vaccine; 2019 Nov; 37(50):7336-7345. PubMed ID: 28647165 [TBL] [Abstract][Full Text] [Related]
14. Vaccine value profile for herpes simplex virus. Johnston C; Scheele S; Bachmann L; Boily MC; Chaiyakunapruk N; Deal C; Delany-Moretlwe S; Lee S; Looker K; Marshall C; Mello MB; Ndowa F; Gottlieb S Vaccine; 2024 Jul; 42(19S1):S82-S100. PubMed ID: 39003018 [TBL] [Abstract][Full Text] [Related]
15. [Vaccines as an approach to the immunocorrection in herpetic infections]. Barinskiĭ IF; Alimbarova LM; Lazarenko AA; Makhmudov FR; Sergeev OV Vopr Virusol; 2014; 59(1):5-11. PubMed ID: 25065139 [TBL] [Abstract][Full Text] [Related]
16. HF10, an attenuated herpes simplex virus (HSV) type 1 clone, lacks neuroinvasiveness and protects mice against lethal challenge with HSV types 1 and 2. Mori I; Liu B; Goshima F; Ito H; Koide N; Yoshida T; Yokochi T; Kimura Y; Nishiyama Y Microbes Infect; 2005 Dec; 7(15):1492-500. PubMed ID: 16054416 [TBL] [Abstract][Full Text] [Related]
17. Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknown. Chentoufi AA; Kritzer E; Yu DM; Nesburn AB; Benmohamed L Clin Dev Immunol; 2012; 2012():187585. PubMed ID: 22548113 [TBL] [Abstract][Full Text] [Related]
18. Herpes simplex: insights on pathogenesis and possible vaccines. Koelle DM; Corey L Annu Rev Med; 2008; 59():381-95. PubMed ID: 18186706 [TBL] [Abstract][Full Text] [Related]
19. Development of prophylactic vaccines for genital and neonatal herpes. Jones CA; Cunningham AL Expert Rev Vaccines; 2003 Aug; 2(4):541-9. PubMed ID: 14711338 [TBL] [Abstract][Full Text] [Related]
20. Use of the Guinea pig model of genital herpes to evaluate vaccines and antivirals: Review. Bernstein DI Antiviral Res; 2020 Aug; 180():104821. PubMed ID: 32544409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]